Evidence map›Paper›PMID 33615056›Full record

ArticleKidney international reports2021

Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis-International Results from PDOPPS.

Simon J Davies, Junhui Zhao, Hal Morgenstern, Jarcy Zee, Brian Bieber, Douglas S Fuller, James A Sloand, Andreas Vychytil, Hideki Kawanishi, David W Johnson and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Mineralocorticoid Receptor Antagonists in Dialysis.American journal of nephrology · 2026
    Review
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Peritoneal dialysis-related infections in elderly patients.Clinical and experimental nephrology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Peritoneal Dialysis-Related Peritonitis Caused byCase reports in nephrology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 10 countries.

Simon J DaviesFaculty of Medicine and Health Sciences, Keele University, Keele, UK.
Junhui ZhaoArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Hal MorgensternDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Jarcy ZeeArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Brian BieberArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Douglas S FullerArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
James A SloandJAS Renaissance, Chicago, Illinois, USA.
Andreas VychytilMedical University of Vienna, Vienna, Austria.
Hideki KawanishiTsuchiya General Hospital, Hiroshima, Japan.
David W JohnsonDepartment of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Angela Yee-Moon WangUniversity of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Talerngsak KanjananbuchCenter of Excellence in Kidney Metabolic Disorders and Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok Thailand.
Sarinya BoongirdRenal Unit, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Thyago P MoraesPontificia Universidade Catolica do Parana, Curitiba, Brazil.
Sunil V BadveSt. George Hospital, Sydney, New South Wales, Australia.
Ronald L PisoniArbor Research Collaborative for Health, Ann Arbor, Michigan, USA.
Jeffrey PerlSt. Michael's Hospital, Toronto, Ontario, Canada.
PDOPPS Dialysis Prescription and Fluid Management Working Group
Arbor Research Collaborative for Health · USChulalongkorn University · THHiroshima General Hospital · JPKeele University · GBKidney Health Australia · AUMahidol University · THMedical University of Vienna · ATPontifícia Universidade Católica do Paraná · BRRenaissance Services (United States) · USSt. Michael's Hospital · CAThe George Institute for Global Health · AUUniversity of Hong Kong · HKUniversity of Michigan · US

Funding

Optimizing Prevention of Peritoneal Dialysis-Associated Peritonitis: An Ancillary Study of the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)R01HS025756 · AHRQ · ARBOR RESEARCH COLLABORATIVE FOR HEALTH · PI PERL, JEFFREY, PISONI, RONALD LEE · 2018 to 2022
$2.2M
AHRQ HHS R01 HS025756
6 · The paper itself

Abstract

introductionHypokalemia, including normal range values <4 mEq/l, has been associated with increased peritonitis and mortality in patients with peritoneal dialysis. This study sought to describe international variation in hypokalemia, potential modifiable hypokalemia risk factors, and the covariate-adjusted relationship of hypokalemia with peritonitis and mortality.

methodsBaseline serum potassium was determined in 7421 patients from 7 countries in the Peritoneal Dialysis Outcomes and Practice Patterns Study (2014-2017). Association of baseline patient and treatment factors with subsequent serum potassium <4 mEq/l was evaluated by logistic regression, whereas baseline serum potassium levels (4-month average and fraction of 4 months having hypokalemia) on clinical outcomes was assessed by Cox regression.

resultsHypokalemia was more prevalent in Thailand and among black patients in the United States. Characteristics/treatments associated with potassium <4 mEq/l included protein-energy wasting indicators, lower urine volume, lower blood pressure, higher dialysis dose, greater diuretic use, and not being prescribed a renin-angiotensin system inhibitor. Persistent hypokalemia (all 4 months vs. 0 months over the 4-month exposure period) was associated with 80% higher subsequent peritonitis rates (at K <3.5 mEq/l) and 40% higher mortality (at K <4.0 mEq/l) after extensive case mix/potential confounding adjustments. Furthermore, adjusted peritonitis rates were higher if having mean serum K over 4 months <3.5 mEq/l versus 4.0-4.4 mEq/l (hazard ratio, 1.15 [95% confidence interval, 0.96-1.37]), largely because of Gram-positive/culture-negative infections.

conclusionsPersistent hypokalemia is associated with higher mortality and peritonitis even after extensive adjustment for patient factors. Further studies are needed to elucidate mechanisms of these poorer outcomes and modifiable risk factors for persistent hypokalemia.

Indexed as

hypokalemiamortalityPDOPPSperitoneal dialysisperitonitispotassium

Identifiers

PMID33615056
PMCPMC7879114
OpenAlexW3109570262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.